Haematologica (Jul 2024)
Extending duration of letermovir prophylaxis in haploidentical stem cell transplantation
- Pongthep Vittayawacharin,
- Benjamin J. Lee,
- Shawn Griffin,
- Jean Doh,
- Julie Smith,
- Hannah Nam,
- Emily Blodget,
- Deepa Jeyakumar,
- Piyanuch Kongtim,
- Stefan O. Ciurea
Affiliations
- Pongthep Vittayawacharin
- Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, California, USA; Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok
- Benjamin J. Lee
- Department of Pharmacy, University of California Irvine Health, Orange, CA, USA; Department of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, California
- Shawn Griffin
- Department of Pharmacy, University of California Irvine Health, Orange, CA, USA; Department of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, California
- Jean Doh
- Department of Pharmacy, University of California Irvine Health, Orange, CA, USA; Department of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, California
- Julie Smith
- Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, California
- Hannah Nam
- Division of Infectious Diseases, Department of Medicine, University of California Irvine, California
- Emily Blodget
- Division of Infectious Diseases, Department of Medicine, University of California Irvine, California
- Deepa Jeyakumar
- Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, California
- Piyanuch Kongtim
- Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, California
- Stefan O. Ciurea
- Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, California
- DOI
- https://doi.org/10.3324/haematol.2024.285766
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
